APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microgravity Pharmaceutical Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Microgravity Pharmaceutical Manufacturing Market Outlook and Growth Opportunities 2026

3 March 2026195 pages

Choose your research edition.

Industry ResearchMicrogravity Pharmaceutical Manufacturing Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Microgravity Pharmaceutical Manufacturing Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Microgravity Pharmaceutical Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microgravity Pharmaceutical Manufacturing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Microgravity Pharmaceutical Manufacturing Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Microgravity Pharmaceutical Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microgravity Pharmaceutical Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microgravity Pharmaceutical Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microgravity Pharmaceutical Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microgravity Pharmaceutical Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microgravity Pharmaceutical Manufacturing market include Space Pharma, Varda Space Industries, Eli Lilly, Amgen and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Microgravity Pharmaceutical Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microgravity Pharmaceutical Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microgravity Pharmaceutical Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microgravity Pharmaceutical Manufacturing market.

Microgravity Pharmaceutical Manufacturing Segment by Company

Space Pharma

Varda Space Industries

Eli Lilly

Amgen

Merck

Microgravity Pharmaceutical Manufacturing Segment by Type

Protein Crystal Growth

Microbial Fermentation and Mutagenesis

Construction of Advanced Disease Models

Microgravity Pharmaceutical Manufacturing Segment by Application

Pharmaceutical Companies

Biotechnology Companies

Microgravity Pharmaceutical Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Microgravity Pharmaceutical Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Microgravity Pharmaceutical Manufacturing key companies, revenue, market share, and recent developments.

3. To split the Microgravity Pharmaceutical Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Microgravity Pharmaceutical Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microgravity Pharmaceutical Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze Microgravity Pharmaceutical Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microgravity Pharmaceutical Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microgravity Pharmaceutical Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microgravity Pharmaceutical Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microgravity Pharmaceutical Manufacturing industry.

Chapter 3: Detailed analysis of Microgravity Pharmaceutical Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Microgravity Pharmaceutical Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Microgravity Pharmaceutical Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microgravity Pharmaceutical Manufacturing Industry Trends Table 2. Microgravity Pharmaceutical Manufacturing Industry Drivers Table 3. Microgravity Pharmaceutical Manufacturing Industry Opportunities and Challenges Table 4. Microgravity Pharmaceutical Manufacturing Industry Restraints Table 5. Global Microgravity Pharmaceutical Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microgravity Pharmaceutical Manufacturing Revenue Share by Company (2021-2026) Table 7. Global Microgravity Pharmaceutical Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Microgravity Pharmaceutical Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global Microgravity Pharmaceutical Manufacturing Company, Product Type & Application Table 10. Global Microgravity Pharmaceutical Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Microgravity Pharmaceutical Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Protein Crystal Growth Table 15. Significant Companies of Microbial Fermentation and Mutagenesis Table 16. Significant Companies of Construction of Advanced Disease Models Table 17. Global Microgravity Pharmaceutical Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Microgravity Pharmaceutical Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Microgravity Pharmaceutical Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Type (2021-2026) Table 21. Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Pharmaceutical Companies Table 23. Significant Companies of Biotechnology Companies Table 24. Global Microgravity Pharmaceutical Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Microgravity Pharmaceutical Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Microgravity Pharmaceutical Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Application (2021-2026) Table 28. Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Application (2027-2032) Table 29. Global Microgravity Pharmaceutical Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Microgravity Pharmaceutical Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Region (2021-2026) Table 32. Global Microgravity Pharmaceutical Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Region (2027-2032) Table 34. Global Microgravity Pharmaceutical Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Microgravity Pharmaceutical Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Microgravity Pharmaceutical Manufacturing Sales Value Market Share by Country (2021-2026) Table 37. Global Microgravity Pharmaceutical Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Microgravity Pharmaceutical Manufacturing Sales Value Market Share by Country (2027-2032) Table 39. Space Pharma Company Information Table 40. Space Pharma Business Overview Table 41. Space Pharma Microgravity Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Space Pharma Microgravity Pharmaceutical Manufacturing Product Portfolio Table 43. Space Pharma Recent Development Table 44. Varda Space Industries Company Information Table 45. Varda Space Industries Business Overview Table 46. Varda Space Industries Microgravity Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Varda Space Industries Microgravity Pharmaceutical Manufacturing Product Portfolio Table 48. Varda Space Industries Recent Development Table 49. Eli Lilly Company Information Table 50. Eli Lilly Business Overview Table 51. Eli Lilly Microgravity Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Eli Lilly Microgravity Pharmaceutical Manufacturing Product Portfolio Table 53. Eli Lilly Recent Development Table 54. Amgen Company Information Table 55. Amgen Business Overview Table 56. Amgen Microgravity Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Amgen Microgravity Pharmaceutical Manufacturing Product Portfolio Table 58. Amgen Recent Development Table 59. Merck Company Information Table 60. Merck Business Overview Table 61. Merck Microgravity Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Merck Microgravity Pharmaceutical Manufacturing Product Portfolio Table 63. Merck Recent Development Table 64. Research Programs/Design for This Report Table 65. Authors List of This Report Table 66. Secondary Sources Table 67. Primary Sources List of Figures Figure 1. Microgravity Pharmaceutical Manufacturing Product Image Figure 2. Global Microgravity Pharmaceutical Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microgravity Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global Microgravity Pharmaceutical Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Protein Crystal Growth Image Figure 8. Microbial Fermentation and Mutagenesis Image Figure 9. Construction of Advanced Disease Models Image Figure 10. Global Microgravity Pharmaceutical Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Microgravity Pharmaceutical Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Type (2021-2032) Figure 13. Pharmaceutical Companies Image Figure 14. Biotechnology Companies Image Figure 15. Global Microgravity Pharmaceutical Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Microgravity Pharmaceutical Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Application (2021-2032) Figure 18. Global Microgravity Pharmaceutical Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Microgravity Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Microgravity Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Microgravity Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Microgravity Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Microgravity Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Protein Crystal Growth
  • Microbial Fermentation and Mutagenesis
  • Construction of Advanced Disease Models
Applications
  • Pharmaceutical Companies
  • Biotechnology Companies
Companies covered
  • Space Pharma
  • Varda Space Industries
  • Eli Lilly
  • Amgen
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microgravity Pharmaceutical Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microgravity Pharmaceutical Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Microgravity Pharmaceutical Manufacturing Market Dynamics
  1. 2.1 Microgravity Pharmaceutical Manufacturing Industry Trends
  2. 2.2 Microgravity Pharmaceutical Manufacturing Industry Drivers
  3. 2.3 Microgravity Pharmaceutical Manufacturing Industry Opportunities and Challenges
  4. 2.4 Microgravity Pharmaceutical Manufacturing Industry Restraints
3 Microgravity Pharmaceutical Manufacturing Market by Company
  1. 3.1 Global Microgravity Pharmaceutical Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global Microgravity Pharmaceutical Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global Microgravity Pharmaceutical Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global Microgravity Pharmaceutical Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global Microgravity Pharmaceutical Manufacturing Company Product Type and Application
  6. 3.6 Global Microgravity Pharmaceutical Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Microgravity Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Microgravity Pharmaceutical Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Microgravity Pharmaceutical Manufacturing Market by Type
  1. 4.1 Microgravity Pharmaceutical Manufacturing Type Introduction
  2. 4.1.1 Protein Crystal Growth
  3. 4.1.2 Microbial Fermentation and Mutagenesis
  4. 4.1.3 Construction of Advanced Disease Models
  5. 4.2 Global Microgravity Pharmaceutical Manufacturing Sales Value by Type
  6. 4.2.1 Global Microgravity Pharmaceutical Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Microgravity Pharmaceutical Manufacturing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Type (2021-2032)
5 Microgravity Pharmaceutical Manufacturing Market by Application
  1. 5.1 Microgravity Pharmaceutical Manufacturing Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Biotechnology Companies
  4. 5.2 Global Microgravity Pharmaceutical Manufacturing Sales Value by Application
  5. 5.2.1 Global Microgravity Pharmaceutical Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Microgravity Pharmaceutical Manufacturing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Microgravity Pharmaceutical Manufacturing Sales Value Share by Application (2021-2032)
6 Microgravity Pharmaceutical Manufacturing Regional Value Analysis
  1. 6.1 Global Microgravity Pharmaceutical Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microgravity Pharmaceutical Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Microgravity Pharmaceutical Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Microgravity Pharmaceutical Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America Microgravity Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe Microgravity Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Microgravity Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America Microgravity Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Microgravity Pharmaceutical Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Microgravity Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Microgravity Pharmaceutical Manufacturing Country-level Value Analysis
  1. 7.1 Global Microgravity Pharmaceutical Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microgravity Pharmaceutical Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Microgravity Pharmaceutical Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Microgravity Pharmaceutical Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Microgravity Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Microgravity Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Microgravity Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Space Pharma
  2. 8.1.1 Space Pharma Company Information
  3. 8.1.2 Space Pharma Business Overview
  4. 8.1.3 Space Pharma Microgravity Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Space Pharma Microgravity Pharmaceutical Manufacturing Product Portfolio
  6. 8.1.5 Space Pharma Recent Developments
  7. 8.2 Varda Space Industries
  8. 8.2.1 Varda Space Industries Company Information
  9. 8.2.2 Varda Space Industries Business Overview
  10. 8.2.3 Varda Space Industries Microgravity Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Varda Space Industries Microgravity Pharmaceutical Manufacturing Product Portfolio
  12. 8.2.5 Varda Space Industries Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Microgravity Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Microgravity Pharmaceutical Manufacturing Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Amgen
  20. 8.4.1 Amgen Company Information
  21. 8.4.2 Amgen Business Overview
  22. 8.4.3 Amgen Microgravity Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Microgravity Pharmaceutical Manufacturing Product Portfolio
  24. 8.4.5 Amgen Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Microgravity Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Microgravity Pharmaceutical Manufacturing Product Portfolio
  30. 8.5.5 Merck Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst